Bone Mass and Metabolism in Whipple's Disease: The Role of Hypogonadism

References

• Bayless TM, Knox DL. Whipple’s disease: a multisystemic infection. N Engl J Med 1979;300:920–1.
   PubMed Web of Science ®Google Scholar
• Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med 1992;327:293–301.
   PubMed Web of Science ®Google Scholar
• Maizel H, Ruffin JM, Dobbins WO. Whipple’s disease: a review of 19 patients from one hospital and a review of the literature since 1950. Medicine 1970;49: 175–205.
   Google Scholar
• Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc 1988;63: 539–51.
   Google Scholar
• Corazza GR, Di Sario A, Cecchetti L, Tarozzi C, Corrao G, Bernardi M, et al. Bone mass and metabolism in patients with celiac disease. Gastroenterology 1995;109:122–8.
   PubMed Web of Science ®Google Scholar
• Gosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031–9.
   PubMedGoogle Scholar
• Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985;103:855–60.
   PubMed Web of Science ®Google Scholar
• Sellin JH, Meredith SC, Kelly S, Schneir H, Rosenberg IH. Prospective evaluation of metabolic bone disease after jejunoileal bypass. Gastroenterology 1984;87:123–9.
   Google Scholar
• Klein KB, Orwoll ES, Lieberman DA, Meier DE, McClune MR, Parfitt AM. Metabolic bone disease in asymptomatic men after partial gastrectomy with Billroth II anastomosis. Gastroenterology 1987;92:608–16.
   PubMed Web of Science ®Google Scholar
• Dobbins III WO. Whipple’s disease. Springfield (IL): Charles C Thomas; 1987.
   Google Scholar
• Gillin JS, Urmacher C, West R, Shike M. Disseminated Mycobacterium avium-intracellular infection in acquired immunodeficiency syndrome mimicking Whipple’s disease. Gastroenterology 1983;85:1185–91.
   Google Scholar
• Keinath RD, Merrell DE, Vlietstra R, Dobbins WO. Antibiotic treatment and relapse in Whipple’s disease. Long-term follow- up of 88 patients. Gastroenterology 1985;88:1867–73.
   Google Scholar
• Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Min Res 1994;9:1137–41.
   PubMed Web of Science ®Google Scholar
• Kelepouris N, Harper KD, Gannon F, Kaplan FS, Hacdad JG. Severe osteoporosis in men. Ann Intern Med 1995;123:452–60.
   PubMed Web of Science ®Google Scholar
• Nussbaum SR, Zahradnik RJ, Lavigne JR, Brennan GL, Nozawaling K, Kim LY, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987;33:1364–7.
   PubMed Web of Science ®Google Scholar
• Schilling H, Haschke F, Schatten C, Schmid M, Woloszczuk W, Steffen I, et al. High total and free 1,25-dihydroxyvitamin D concentrations in serum of premature infants. Acta Pediatr Scand 1990;79:36–40.
   PubMed Web of Science ®Google Scholar
• Mellko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay for the carboxy-terminal propeptide of human type I procollagen. Clin Chem 1990;36:1328–32.
   PubMedGoogle Scholar
• Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline-cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635–40.
   Google Scholar
• Katis JG. Whipple’s disease. McGill Med J 1959;28:66–70.
   PubMedGoogle Scholar
• Ayoub WT, Davis DE, Torretti D, Viozzi FJ. Bone destruction and ankylosis in Whipple’s disease. J Rheumatol 1982;9:930–1.
   PubMedGoogle Scholar
• Kelly JJ, Weisiger BB. The arthritis of Whipple’s disease. Arth Rheum 1963;6:615–32.
   PubMed Web of Science ®Google Scholar
• Heully MMF, Gaucher P, Penin F, Bas M, Fays JG, Grignon P, et al. Maladie de Whipple associée à un mesentere commun. Etude en microscopie optique et electronique. Arch Franc Mal App Dig 1968;57:699–714.
   Google Scholar
• James TN, Bulkley BH, McAllister HA, Kent SP. Testicular lesions in Whipple’s disease. J Lab Clin Med 1985;105:259–67.
   PubMedGoogle Scholar
• Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, et al. Increases in bone density during treatment of men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1989;69:776–83.
   PubMed Web of Science ®Google Scholar
• Stepan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab 1989;69:523–7.
   Google Scholar
• Goldray D, Weisman Y, Jaccard N, Merdler C, Chen J, Matzkin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone against Decapeptyl. J Clin Endocrinol Metab 1993;76:288–90.
   PubMed Web of Science ®Google Scholar
• Chesnut CH. Theoretical overview: bone development, peak bone mass, bone loss, and fracture risk. Am J Med 1991;91 Suppl 5B:2S–4S.
   Google Scholar
• Golub LM, Ramamurthy NS, Kaneko H, Sasaki T, Rifkin B, McNamara TF. Tetracycline administration prevents diabetes- induced osteopenia in the rat: initial observations. Res Commun Chem Pathol Pharmacol 1990;68:27–40.
   PubMedGoogle Scholar
• Greenwald RA, Simonson BG, Moak SA, Rush SW, Ramamurthy NS, Laskin RS, et al. Inhibition of epiphyseal cartilage collagenase by tetracycline in low phosphate rickets in rat. J Orthop Res 1988;6:695–703.
   PubMed Web of Science ®Google Scholar
• Ramamurthy NS, Vernillo AT, Lee HM, Golub LM, Rifkin BR. The effect of tetracyclines on collagenase activity in UMR 106–01 rat osteoblastic osteosarcoma cells. Res Commun Chem Pathol Pharmacol 1990;70: 323–5.
   Google Scholar
• Gomes BC, Golub LM, Ramamurthy NS. Tetracyclines inhibit parathyroid hormone-induced bone resorption in organ culture. Experientia 1984;40:1273–5.
   Google Scholar